# The Prelieve Trial - Pilot Study to Assess Safety and Efficacy of a Novel Atrial Flow Regulator (AFR) in Heart Failure Patients

> **NCT03030274** · NA · COMPLETED · sponsor: **Occlutech International AB** · enrollment: 106 (actual)

## Conditions studied

- Heart Failure Low Output
- Heart Failure

## Interventions

- **DEVICE:** Occlutech AFR device

## Key facts

- **NCT ID:** NCT03030274
- **Lead sponsor:** Occlutech International AB
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-11
- **Primary completion:** 2021-05-01
- **Final completion:** 2022-03-02
- **Target enrollment:** 106 (ACTUAL)
- **Last updated:** 2022-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03030274

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03030274, "The Prelieve Trial - Pilot Study to Assess Safety and Efficacy of a Novel Atrial Flow Regulator (AFR) in Heart Failure Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03030274. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*